Eyerad.de - In-depth Website Analysis
Eyerad.de is hosted in United Kingdom Eyerad.de has HTTPS protocol. Number of used technologies: 8. First technologies CSS, Html, Html5, Javascript, jQuery, jQuery Cycle, MooTools, Php Number of used javascripts: 14. First javascripts: mootools.js, caption.js, textsizer.js. Number of used analytics tools: 0 Number of used plugins, modules: 2. Its server type is Apache.
eyerad.de: Server & Hosting Details
| IPV4 Encoding (Ip2long) | 100315476 |
|---|---|
| Binary IP address | 101111110101011000101010100 |
| Octal IP address | 576530524 |
| Hexadecimal IP address | 5fab154 |
Tech Insights on eyerad.de
Technology
Number of occurences: 8-
CSS -
Html -
Html5 -
Javascript -
jQuery -
jQuery Cycle -
MooTools -
Php
Javascript
-
mootools.js
-
caption.js
-
textsizer.js
-
silverlight.js
-
wmvplayer.js
-
swfobject.js
-
avreloaded.js
-
jquery.js
-
jquery.cycle.all.min.js
-
jquery.easing.1.3.js
-
jquery.easing.compatibility.js
-
script.js
-
script.responsive.js
Key Factors Influencing Conversion Rates
-
priority_highNot presentClickable call number
-
priority_highNot presentConversion form (contact form, subscribe)
-
priority_highNot presentClickable email
-
priority_highNot presentCTA (Call To Action) button
-
priority_highNot presentList
-
priority_highNot presentImage
-
done_allPresentViewability on small screens
-
priority_highNot presentFacebook sharing
-
priority_highNot presentTwitter sharing
-
priority_highNot presentLinkedin sharing
HTTPS (SSL) Security Overview for Eyerad.de
SSL certificate
- name: /CN=www.coffees.gr
- subject:
- CN: www.coffees.gr
- hash: 1df8ed03
- issuer:
- C: US
- O: GeoTrust Inc.
- OU: Domain Validated SSL
- CN: GeoTrust DV SSL CA - G4
- version: 2
- serialNumber: 173555
- validFrom: 151121195112Z
- validTo: 161222183849Z
- validFrom_time_t: 1448135472
- validTo_time_t: 1482431929
- extensions:
- authorityKeyIdentifier: keyid:0B:50:EC:77:EF:2A:9B:FF:EC:03:A1:0A:FF:AD:C6:E4:2A:18:C7:3E
- authorityInfoAccess: OCSP - URI:http://gu.symcd.com CA Issuers - URI:http://gu.symcb.com/gu.crt
- keyUsage: Digital Signature, Key Encipherment
- extendedKeyUsage: TLS Web Server Authentication, TLS Web Client Authentication
- subjectAltName: DNS:www.coffees.gr, DNS:coffees.gr
- crlDistributionPoints: Full Name: URI:http://gu.symcb.com/gu.crl
- basicConstraints: CA:FALSE
- certificatePolicies: Policy: 2.23.140.1.2.1 CPS: https://www.geotrust.com/resources/repository/legal
Insights About the eyerad.de Domain
| Domain name length | 9 |
|---|---|
| Hyphens | Domain doesn't contain hyphens! |
| Domain name with Hindi letters: | ए ग़ ए र अ द . द ए |
| Domain name with Hebrew letters: | (e) י (e) ר (a) ד . ד (e) |
| Domain name with Cyrillic letters: | e y e р a д . д e |
| Domain name with Arabic letters: | (e) ﻱ (e) ﺭ ﺍ ﺩ . ﺩ (e) |
| Domain name with Greek letters: | ε y ε ρ α δ . δ ε |
| Domain name with Chinese letters: | 伊 吾艾 伊 艾儿 诶 迪 . 迪 伊 |
| Domain without Consonants: | yrd.d |
| Domain without Vowels: | eyea.e |
| Alphabet positions: | e5 y25 e5 r18 a1 d4 . d4 e5 |
|
Domain name pattern: V: Vowel, C: Consonant, N: Number |
V C V C V C . C V |
Metatags and Values Used on Eyerad.de
description
yeRAD SWISS Medical, a privately held company, is the authorized exclusive representative for the Oraya Therapy in Switzerland and other markets. EyeRAD is operating a dedicated ophthalmology IGSRS Center (Image Guided Stereotactic Radiosurgery Center) within the Vista Klinik.
keywords
eye, [eye], eye6D-IGSRS, [6D-IGSRS], 6D-IGSRS6D-IGSRS 6Dimensional - Image Guided Stereotactic Radiosurgery, [6D-IGSRS 6Dimensional - Image Guided Stereotactic Radiosurgery], 6D-IGSRS 6Dimensional - Image Guided Stereotactic Radiosurgery6Dimensional - Image Guided Stereotactic Radiosurgery, [6Dimensional - Image Guided Stereotactic Radiosurgery], 6Dimensional - Image Guided Stereotactic Radiosurgery6Dimensional, [6Dimensional], 6DimensionalImage Guided Stereotactic Radiosurgery, [Image Guided Stereotactic Radiosurgery], Image Guided Stereotactic RadiosurgeryA central blind spot develops, [A central blind spot develops], A central blind spot developsA New Option, [A New Option], A New OptionAAO-APAO Joint Meeting, [AAO-APAO Joint Meeting], AAO-APAO Joint Meetingabnormal blood vessels, [abnormal blood vessels], abnormal blood vesselschoroidal neovascularization, [choroidal neovascularization], choroidal neovascularizationCNV, [CNV], CNVabnormal vessels, [abnormal vessels], abnormal vesselsAction of Radiation Therapy, [Action of Radiation Therapy], Action of Radiation Therapyaflibercept Eylea, [aflibercept Eylea], aflibercept EyleaAge-Related Macular Degeneration, [Age-Related Macular Degeneration], Age-Related Macular DegenerationAMD, [AMD], AMDAMD Alliance International, [AMD Alliance International], AMD Alliance InternationalAMD Alliance International, [AMD Alliance International], AMD Alliance InternationalAMD Been Traditionally Treated?, [AMD Been Traditionally Treated?], AMD Been Traditionally Treated?AMD is an inflammatory disease, [AMD is an inflammatory disease], AMD is an inflammatory diseaseAmdawarenessorg, [Amdawarenessorg], AmdawarenessorgAmerican Academy of Ophthalmology 2013 Annual Meeting AAO, [American Academy of Ophthalmology 2013 Annual Meeting AAO], American Academy of Ophthalmology 2013 Annual Meeting AAOAmerican Macular Degeneration Foundation, [American Macular Degeneration Foundation], American Macular Degeneration Foundationanti-fibrotic effects, [anti-fibrotic effects], anti-fibrotic effectsanti-angiogenic, [anti-angiogenic], anti-angiogenicAnti-Angiogenic, [Anti-Angiogenic], Anti-Angiogenicanti-inflammatory, [anti-inflammatory], anti-inflammatoryAnti-Inflammatory, [Anti-Inflammatory], Anti-InflammatoryAnti-VEGF, [Anti-VEGF], Anti-VEGFanti-VEGF agent, [anti-VEGF agent], anti-VEGF agentAnti-VEGF drugs, [Anti-VEGF drugs], Anti-VEGF drugsAnti-VEGF Treatment For Patients With Wet AMD, [Anti-VEGF Treatment For Patients With Wet AMD], Anti-VEGF Treatment For Patients With Wet AMDINTREPID, [INTREPID], INTREPIDAssociation for Macular Diseases, [Association for Macular Diseases], Association for Macular DiseasesAssociation for Research in Vision and Ophthalmology Annual Meeting 2013 ARVO, [Association for Research in Vision and Ophthalmology Annual Meeting 2013 ARVO], Association for Research in Vision and Ophthalmology Annual Meeting 2013 ARVOAssociation for Research in Vision and Ophthalmology Annual Meeting, [Association for Research in Vision and Ophthalmology Annual Meeting], Association for Research in Vision and Ophthalmology Annual MeetingARVO, [ARVO], ARVOattacks the macula of the eye, [attacks the macula of the eye], attacks the macula of the eyeAutomated Beam Positioning System, [Automated Beam Positioning System], Automated Beam Positioning SystemAvastin, [Avastin], AvastinAxial Length Measurement, [Axial Length Measurement], Axial Length MeasurementAxial Length Measurement of the eye, [Axial Length Measurement of the eye], Axial Length Measurement of the eyeback chamber of the eye, [back chamber of the eye], back chamber of the eyeBasel Vista Klinik Switzerland, [Basel Vista Klinik Switzerland], Basel Vista Klinik SwitzerlandBeam Positioning System, [Beam Positioning System], Beam Positioning Systembevacizumab, [bevacizumab], bevacizumabAvastin®, [Avastin®], Avastin®British and Eire Association of Vitreoretinal Surgeons, [British and Eire Association of Vitreoretinal Surgeons], British and Eire Association of Vitreoretinal SurgeonsBEAVRS, [BEAVRS], BEAVRS+41 79 1262230, [+41 79 1262230], +41 79 1262230, [], CH-4102 Binningen, [CH-4102 Binningen], CH-4102 Binningenclinical trials, [clinical trials], clinical trialsCNV secondary to neovascular AMD, [CNV secondary to neovascular AMD], CNV secondary to neovascular AMDneovascular AMD, [neovascular AMD], neovascular AMDcollimated beams, [collimated beams], collimated beamsCone, [Cone], ConeConjunctiva, [Conjunctiva], Conjunctivacontrol and precision targeting, [control and precision targeting], control and precision targetingCornea, [Cornea], CorneaDelivered non-invasively, [Delivered non-invasively], Delivered non-invasivelyDifficulty distinguishing colors, [Difficulty distinguishing colors], Difficulty distinguishing colorsDifficulty reading, [Difficulty reading], Difficulty readingDifficulty recognizing faces, [Difficulty recognizing faces], Difficulty recognizing facesDigital Fundus Photography, [Digital Fundus Photography], Digital Fundus PhotographyDiscovery Eye Foundation, [Discovery Eye Foundation], Discovery Eye Foundationdisruption of cytokines and leukocytes, [disruption of cytokines and leukocytes], disruption of cytokines and leukocytesDrmed-phys EA Lazaridis, [Drmed-phys EA Lazaridis], Drmed-phys EA Lazaridisdrier retinas, [drier retinas], drier retinasDry AMD, [Dry AMD], Dry AMDearly dry, [early dry], early drylate wet stages, [late wet stages], late wet stagesEase of Use, [Ease of Use], Ease of UseEmail elazaridis@eyeradch, [Email elazaridis@eyeradch], Email elazaridis@eyeradchepiretinal brachytherapy, [epiretinal brachytherapy], epiretinal brachytherapyEURETINA Congress, [EURETINA Congress], EURETINA CongressEuropean Society of Ophthalmology SOE, [European Society of Ophthalmology SOE], European Society of Ophthalmology SOEEuropean Society of Ophthalmology 2013 SOE, [European Society of Ophthalmology 2013 SOE], European Society of Ophthalmology 2013 SOEexact required beam positioning, [exact required beam positioning], exact required beam positioningExciting New Treatment Option, [Exciting New Treatment Option], Exciting New Treatment OptionEye Stabilization Device, [Eye Stabilization Device], Eye Stabilization DeviceEye stabilizing device, [Eye stabilizing device], Eye stabilizing deviceEye stabilizing device, [Eye stabilizing device], Eye stabilizing deviceEye Tracking, [Eye Tracking], Eye TrackingEye tracking module, [Eye tracking module], Eye tracking moduleEye tracking module, [Eye tracking module], Eye tracking moduleEye Tracking System, [Eye Tracking System], Eye Tracking SystemEyeRAD SWISS Medical Center, [EyeRAD SWISS Medical Center], EyeRAD SWISS Medical CenterEyeRad Therapeutics, [EyeRad Therapeutics], EyeRad TherapeuticsFax +41 61 4266001, [Fax +41 61 4266001], Fax +41 61 4266001Fluorescein Angiography, [Fluorescein Angiography], Fluorescein AngiographyFluorescein Angiography FA, [Fluorescein Angiography FA], Fluorescein Angiography FAFoundation Fighting Blindness, [Foundation Fighting Blindness], Foundation Fighting BlindnessFovea, [Fovea], Foveafurther injections, [further injections], further injectionsGerman Ophthalmological Society DOG, [German Ophthalmological Society DOG], German Ophthalmological Society DOGglobe axial length, [globe axial length], globe axial lengthHaupstrasse 55, [Haupstrasse 55], Haupstrasse 55highly collimated beam, [highly collimated beam], highly collimated beamhighly targeted X-rays, [highly targeted X-rays], highly targeted X-rayshighly targeted X-rays for treatment of wet AMD, [highly targeted X-rays for treatment of wet AMD], highly targeted X-rays for treatment of wet AMDHope for eye disease sufferers, [Hope for eye disease sufferers], Hope for eye disease sufferersI-Guide Eye Stabilization Device, [I-Guide Eye Stabilization Device], I-Guide Eye Stabilization DeviceImage Guided Stereotactic Radiosurgery, [Image Guided Stereotactic Radiosurgery], Image Guided Stereotactic Radiosurgeryimage of the retina, [image of the retina], image of the retinaimmersion ultrasonography, [immersion ultrasonography], immersion ultrasonographyimprovement in her vision, [improvement in her vision], improvement in her visioninfo@eyeradch, [info@eyeradch], info@eyeradchinjections of anti-VEGF agents, [injections of anti-VEGF agents], injections of anti-VEGF agentsInnovative Technology, [Innovative Technology], Innovative TechnologyInsight Radio, [Insight Radio], Insight Radiointegrated beam-stop, [integrated beam-stop], integrated beam-stopinterrupting angiogenesis, [interrupting angiogenesis], interrupting angiogenesisINTREPID, [INTREPID], INTREPIDINTREPID identifies ‘best responders’ Fewer anti-VEGF injections among benefits of stereotactic radiotherapy for wet AMD, [INTREPID identifies ‘best responders’ Fewer anti-VEGF injections among benefits of stereotactic radiotherapy for wet AMD], INTREPID identifies ‘best responders’ Fewer anti-VEGF injections among benefits of stereotactic radiotherapy for wet AMDINTREPID Study, [INTREPID Study], INTREPID StudyIntuitive operator interface, [Intuitive operator interface], Intuitive operator interfaceIonizing radiation, [Ionizing radiation], Ionizing radiationIRay, [IRay], IRayIRay, [IRay], IRayIRay Plus Anti-VEGF Treatment for Patients with Wet AMD, [IRay Plus Anti-VEGF Treatment for Patients with Wet AMD], IRay Plus Anti-VEGF Treatment for Patients with Wet AMDIRay System, [IRay System], IRay SystemIRay® Radiotherapy System, [IRay® Radiotherapy System], IRay® Radiotherapy SystemIs Radiation Exposure Dangerous?, [Is Radiation Exposure Dangerous?], Is Radiation Exposure Dangerous?ITV, [ITV], ITVLens, [Lens], Lenslens and optic nerve, [lens and optic nerve], lens and optic nerveLighthouse International, [Lighthouse International], Lighthouse InternationalLimbus, [Limbus], LimbusLocation, [Location], LocationLow-Energy X-ray Tube, [Low-Energy X-ray Tube], Low-Energy X-ray Tubelow-voltage X-ray irradiation system, [low-voltage X-ray irradiation system], low-voltage X-ray irradiation systemlow-voltage, [low-voltage], low-voltageLucentis injections, [Lucentis injections], Lucentis injectionsMacula, [Macula], Maculamacula, [macula], maculaMacular Degeneration International, [Macular Degeneration International], Macular Degeneration InternationalMacular Disease Society, [Macular Disease Society], Macular Disease SocietyMail Online, [Mail Online], Mail OnlineMy Story Stella Chandler, [My Story Stella Chandler], My Story Stella Chandlerneovascular AMD, [neovascular AMD], neovascular AMDneovascular endothelial cells, [neovascular endothelial cells], neovascular endothelial cellsNew hope for macular degeneration, [New hope for macular degeneration], New hope for macular degenerationNew Retina MD, [New Retina MD], New Retina MDnon-invasive, [non-invasive], non-invasivenon-invasive imaging technology, [non-invasive imaging technology], non-invasive imaging technologynon-invasive Oraya Therapy, [non-invasive Oraya Therapy], non-invasive Oraya TherapyOcular Surgery News, [Ocular Surgery News], Ocular Surgery NewsOnCore Opens Medical Center-of-Excellence, [OnCore Opens Medical Center-of-Excellence], OnCore Opens Medical Center-of-Excellenceone late form of the disease, [one late form of the disease], one late form of the diseaseone-time radiotherapy treatment in both eyes, [one-time radiotherapy treatment in both eyes], one-time radiotherapy treatment in both eyesOphthalmic Exams, [Ophthalmic Exams], Ophthalmic ExamsOphthalmology Times, [Ophthalmology Times], Ophthalmology Timesoptic nerve, [optic nerve], optic nerveOptic Nerve – Cranial Nerve II, [Optic Nerve – Cranial Nerve II], Optic Nerve – Cranial Nerve IICranial Nerve II, [Cranial Nerve II], Cranial Nerve IIoptical biometry, [optical biometry], optical biometryOptical Coherence Tomography, [Optical Coherence Tomography], Optical Coherence TomographyOptical Coherence Tomography OCT, [Optical Coherence Tomography OCT], Optical Coherence Tomography OCToptical coherence tomography OCT or eye examination, [optical coherence tomography OCT or eye examination], optical coherence tomography OCT or eye examinationOraya Therapeutics’ INTREPID Study Published in Ophthalmology the Official Journal of the American Academy of Ophthalmology, [Oraya Therapeutics’ INTREPID Study Published in Ophthalmology the Official Journal of the American Academy of Ophthalmology], Oraya Therapeutics’ INTREPID Study Published in Ophthalmology the Official Journal of the American Academy of OphthalmologyOraya Therapy, [Oraya Therapy], Oraya TherapyOraya Therapy A New Option, [Oraya Therapy A New Option], Oraya Therapy A New OptionOraya Therapy group, [Oraya Therapy group], Oraya Therapy groupOraya Therapy Software, [Oraya Therapy Software], Oraya Therapy SoftwareOxford Ophthalmological Congress 2013, [Oxford Ophthalmological Congress 2013], Oxford Ophthalmological Congress 2013Patient Comfort, [Patient Comfort], Patient ComfortPatient interface, [Patient interface], Patient interfacePatient interface, [Patient interface], Patient interfacePatients with Wet AMD, [Patients with Wet AMD], Patients with Wet AMDPCV aneurysmal bulge, [PCV aneurysmal bulge], PCV aneurysmal bulgepegaptanib Macugen®, [pegaptanib Macugen®], pegaptanib Macugen®Polypoidal Choroidal Vasculopathy PCV, [Polypoidal Choroidal Vasculopathy PCV], Polypoidal Choroidal Vasculopathy PCVportable chest X-ray machine, [portable chest X-ray machine], portable chest X-ray machinepositioning mechanism, [positioning mechanism], positioning mechanismPrecision-controlled X-ray tube, [Precision-controlled X-ray tube], Precision-controlled X-ray tubePrecision-controlled X-ray tube, [Precision-controlled X-ray tube], Precision-controlled X-ray tubePREVENT AMD?, [PREVENT AMD?], PREVENT AMD?Principles of Radiation Treatment for Wet AMD, [Principles of Radiation Treatment for Wet AMD], Principles of Radiation Treatment for Wet AMDPRN Lucentis EURETINA Congress in Milan Italy, [PRN Lucentis EURETINA Congress in Milan Italy], PRN Lucentis EURETINA Congress in Milan Italyprogressive disease, [progressive disease], progressive diseasepro-inflammatory cytokines, [pro-inflammatory cytokines], pro-inflammatory cytokinesPupil, [Pupil], PupilRadiation Therapy for Neovascular Age-related Macular Degeneration, [Radiation Therapy for Neovascular Age-related Macular Degeneration], Radiation Therapy for Neovascular Age-related Macular DegenerationRadiation Treatment for Wet AMD, [Radiation Treatment for Wet AMD], Radiation Treatment for Wet AMDRadiation Work to Treat Wet AMD?, [Radiation Work to Treat Wet AMD?], Radiation Work to Treat Wet AMD?Radiotherapy breakthrough to treat wet AMD, [Radiotherapy breakthrough to treat wet AMD], Radiotherapy breakthrough to treat wet AMDRanibizumab Lucentis®, [Ranibizumab Lucentis®], Ranibizumab Lucentis®Readers Digest, [Readers Digest], Readers Digestreduction in anti-VEGF injections, [reduction in anti-VEGF injections], reduction in anti-VEGF injectionsreduction of inflammation, [reduction of inflammation], reduction of inflammationRetina, [Retina], RetinaRetina in Progress, [Retina in Progress], Retina in ProgressRetina Today, [Retina Today], Retina TodayRevolutionary Treatment for AMD Launched, [Revolutionary Treatment for AMD Launched], Revolutionary Treatment for AMD Launchedrisk factors for AMD?, [risk factors for AMD?], risk factors for AMD?RISK FACTORS FOR AMD?, [RISK FACTORS FOR AMD?], RISK FACTORS FOR AMD?Rod, [Rod], RodRoyal College of Ophthalmologists Annual Congress 2013, [Royal College of Ophthalmologists Annual Congress 2013], Royal College of Ophthalmologists Annual Congress 2013scattered radiation levels, [scattered radiation levels], scattered radiation levelsSclera, [Sclera], ScleraSelf-contained Automated Beam Positioning System, [Self-contained Automated Beam Positioning System], Self-contained Automated Beam Positioning Systemsharpest central vision, [sharpest central vision], sharpest central visionSigns and Symptoms of Wet AMD?, [Signs and Symptoms of Wet AMD?], Signs and Symptoms of Wet AMD?SMT Online, [SMT Online], SMT Onlinespecial optical device laser interferometer, [special optical device laser interferometer], special optical device laser interferometerStarts with Oraya, [Starts with Oraya], Starts with Orayastate-of-the- art technology, [state-of-the- art technology], state-of-the- art technologystereotactic low-voltage X-rays, [stereotactic low-voltage X-rays], stereotactic low-voltage X-raysStereotactic Radiotherapy, [Stereotactic Radiotherapy], Stereotactic Radiotherapystereotactic, [stereotactic], stereotacticstereotactic, [stereotactic], stereotacticStraight lines or surfaces appear wavy, [Straight lines or surfaces appear wavy], Straight lines or surfaces appear wavytargeting of the macula, [targeting of the macula], targeting of the maculaTel +41 61 4266000, [Tel +41 61 4266000], Tel +41 61 4266000The American Society of Retina Specialists and Genentech, [The American Society of Retina Specialists and Genentech], The American Society of Retina Specialists and GenentechThe Discovery Eye Foundation supports research education advocacy and treatments of sight threatening eye diseases, [The Discovery Eye Foundation supports research education advocacy and treatments of sight threatening eye diseases], The Discovery Eye Foundation supports research education advocacy and treatments of sight threatening eye diseasesThe non-invasive Oraya Therapy, [The non-invasive Oraya Therapy], The non-invasive Oraya TherapyThe symptoms can appear suddenly or may be noticed over time especially if a diagnosis of dry AMD has already been made Symptoms may include the following, [The symptoms can appear suddenly or may be noticed over time especially if a diagnosis of dry AMD has already been made Symptoms may include the following], The symptoms can appear suddenly or may be noticed over time especially if a diagnosis of dry AMD has already been made Symptoms may include the followingThe Wall Street Journal, [The Wall Street Journal], The Wall Street JournalThe X-ray beam that could end painful jabs for aging eyes, [The X-ray beam that could end painful jabs for aging eyes], The X-ray beam that could end painful jabs for aging eyesThis Won’t Hurt A Bit, [This Won’t Hurt A Bit], This Won’t Hurt A Bittopical anesthetic, [topical anesthetic], topical anesthetictreatment of neovascular AMD, [treatment of neovascular AMD], treatment of neovascular AMDtreatment of wet AMD, [treatment of wet AMD], treatment of wet AMDtreatment-planning model, [treatment-planning model], treatment-planning modelunder the macula, [under the macula], under the maculaVEGF Vascular Endothelial Growth Factor, [VEGF Vascular Endothelial Growth Factor], VEGF Vascular Endothelial Growth Factorvision loss, [vision loss], vision lossVision Magazine Issue 60, [Vision Magazine Issue 60], Vision Magazine Issue 60VisionAware, [VisionAware], VisionAwareVista Klinik, [Vista Klinik], Vista Klinikvisual acuity, [visual acuity], visual acuityVisual Acuity Test, [Visual Acuity Test], Visual Acuity TestVisual Acuity Test an OCT and an Axial Length Measurement, [Visual Acuity Test an OCT and an Axial Length Measurement], Visual Acuity Test an OCT and an Axial Length Measurementvitamins C and E selenium and carotenoids fresh fruits and dark leafy green vegetables, [vitamins C and E selenium and carotenoids fresh fruits and dark leafy green vegetables], vitamins C and E selenium and carotenoids fresh fruits and dark leafy green vegetablesVitreous, [Vitreous], VitreousWet AMD, [Wet AMD], Wet AMDWet AMD Therapy, [Wet AMD Therapy], Wet AMD TherapyWet AMD, [Wet AMD], Wet AMDWet AMD?, [Wet AMD?], Wet AMD?WHAT ARE SIGNS AND SYMPTOMS OF WET AMD?, [WHAT ARE SIGNS AND SYMPTOMS OF WET AMD?], WHAT ARE SIGNS AND SYMPTOMS OF WET AMD?What Tests May Be Done In The Ophthalmologist’s Office Before The Procedure?, [What Tests May Be Done In The Ophthalmologist’s Office Before The Procedure?], What Tests May Be Done In The Ophthalmologist’s Office Before The Procedure?Why Might I Need Both Radiation and Anti-VEGF?, [Why Might I Need Both Radiation and Anti-VEGF?], Why Might I Need Both Radiation and Anti-VEGF?X-ray Aid For Eyes, [X-ray Aid For Eyes], X-ray Aid For EyesYahoo!7 News, [Yahoo!7 News], Yahoo!7 NewsYour ophthalmologist, [Your ophthalmologist], Your ophthalmologistzero injections, [zero injections], zero injections
viewport
initial-scale = 1.0, maximum-scale = 1.0, user-scalable = no, width = device-width
robots
index, follow
title
arxiki
author
Administrator
generator
Joomla! 1.5 - Open Source Content Management
Main nameservers for eyerad.de
- ns2.domainhostservers.net
- ns1.domainhostservers.net
- eyerad.de
Target
- gdipla.rainhost.gr
Common Mistyped Domains
Common spelling mistakes people make when searching for eyerad.de.
Possible TLDs
List of possible domain names with other tlds